Results 231 to 240 of about 109,705 (362)

How I manage cold agglutinin disease

British Journal of Haematology, 2011
S. Berentsen
semanticscholar   +1 more source

Protein‐Like Polymers Targeting Keap1/Nrf2 as Therapeutics for Myocardial Infarction

Advanced Materials, Volume 37, Issue 27, July 10, 2025.
We describe a Keap1 targeting protein‐like polymer (PLP) which activates Nrf2, an important cytoprotective transcription factor for relieving myocardial infarction‐induced oxidative stress. This PLP increases cell survival in vitro in multiple relevant cardiac cell types and elicits pro‐reparative responses, improving cardiac function in a preclinical ...
Joshua M. Mesfin, Kendal P. Carrow, Alexander Chen, Madeline P. Hopps, JoJo J. Holm, Quincy P. Lyons, Michael B. Nguyen, Jervaughn D. Hunter, Assa Magassa, Elyse G. Wong, Kate Reimold, Sriya N. Paleti, Emily Gardner, Matthew P. Thompson, Colin G. Luo, Xiaoyu Zhang, Karen L. Christman, Nathan C. Gianneschi   +17 more
wiley   +1 more source

<i>Wisteria floribunda</i> agglutinin enhances <i>Zaire ebolavirus</i> entry through interactions at specific <i>N</i>-linked glycosylation sites on the virus glycoprotein complex. [PDF]

J Gen Virol
Duncan JD, Pathak M, King BJ, Bamber H, Radford P, Dey J, Richardson C, Astbury S, McClure P, Ball JK, Urbanowicz RA, Tarr AW.   +11 more
europepmc   +1 more source

THE REMOVAL OF AGGLUTININ FROM SENSITIZED MOTILE BACTERIA [PDF]

, 1928
John B. Nelson
openalex   +1 more source

Production of Rh Agglutinins [PDF]

BMJ, 1948
openaire   +3 more sources

The FGF13‐Caveolin‐1 Axis: A Key Player in the Pathogenesis of Doxorubicin‐ and D‐Galactose‐Induced Premature Cardiac Aging

Advanced Science, Volume 12, Issue 25, July 3, 2025.
The FGF13 level is significantly downregulated in premature aging murine hearts subject to D‐galactose and Doxorubicin. FGF13 overexpression and deficiency exacerbated and alleviated Doxorubicin/D‐galactose‐induced myocardial aging characteristics and functional impairment, respectively.
Enzhao Shen, Yuecheng Wu, Weijian Ye, Sihang Li, Junjie Zhu, Meifan Jiang, Zhicheng Hu, Gaoyong Cao, Xiaojing Yi, Fan Li, Zhouhao Tang, Xiaokun Li, Kwang Youl Lee, Litai Jin, Xu Wang, Weitao Cong   +15 more
wiley   +1 more source

Lipopolysaccharide Detection with Glycan-Specific Lectins-a Nonspecific Binding Approach Applied to Surface Plasmon Resonance. [PDF]

ACS Omega
Lamarre M, Boudreau D.
europepmc   +1 more source

Functional consequences of mannose and asialoglycoprotein receptor ablation [PDF]

, 2016
Baenziger, Jacques U, Coonce, Marcy, Dveksler, Gabriela, Fiete, Dorothy, Mi, Yiling, Steirer, Lindsay, Townsend, R. Reid   +6 more
core   +2 more sources

Opportunities to improve surveillance of hepatocellular carcinoma in Australia

Medical Journal of Australia, EarlyView.
Jess Howell, Jon D Emery, Stuart Roberts, Alexander J Thompson, Michael Ng, Jacob George, Barbara A Leggett, Edmund Tse, Bella Nguyen, Troy Combo, Alan J Wigg   +10 more
wiley   +1 more source

Cardiac Slc25a49‐Mediated Energy Reprogramming Governs Doxorubicin‐Induced Cardiomyopathy through the G6P–AP‐1–Sln Axis

Advanced Science, Volume 12, Issue 26, July 10, 2025.
Doxorubicin‐induced cardiomyopathy involves mitochondrial energy metabolism dysfunction, exacerbated by cardiomyocyte‐specific Slc25a49 deficiency via oxidative phosphorylation (OXPHOS) suppression and glycolysis activation. The Slc25a49–glucose‐6‐phosphate (G6P)–activator protein‐1 (AP‐1) axis drives myocardial injury by upregulating Sln, disrupting ...
Sitong Wan, Jingyi Qi, Yi Xia, Chang Fan, Teng Xu, Xu Zhang, Jiaxin Shi, Chenxuan Wang, Yitong Cheng, Dongyuan Zhang, Rong Liu, Yinhua Zhu, Changchang Cao, Dekui Jin, Peng An, Yongting Luo, Junjie Luo   +16 more
wiley   +1 more source